• 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Astellas

Astellas is committed to advancing transformative therapies in Primary Focus Blindness and Regeneration to restore sight and reduce fear of deteriorating vision.

Our mission is to identify, develop and deliver next-generation treatments that protect or restore vision. By combining our expertise in eye biology with cutting-edge technologies, we’re pioneering new approaches including novel cell- and gene-based therapies.

With a pipeline of several regenerative medicine programs, we have the potential to transform the treatment of multiple eye diseases.

Contact Details:
Name: Mr Alvin Kok
Email: alvin.kok@astellas.com

Abstract submission deadline extended

Important dates
Good News! Abstract Submission Now Open Until 21 February 2026